CA 19-9 Velocity Predicts Disease-Free Survival and Overall Survival After Pancreatectomy of Curative Intent-Reference-Cited by-同舟云学术

CA 19-9 Velocity Predicts Disease-Free Survival and Overall Survival After Pancreatectomy of Curative Intent

Published:2008-10-30 Issue:2 Volume:13 Page:349-353
ISSN:1091-255X
Container-title:Journal of Gastrointestinal Surgery
language:en
Short-container-title:J Gastrointest Surg

Author:

Hernandez Jonathan M.,Cowgill Sarah M.,Al-Saadi Sam,Collins Amy,Ross Sharona B.,Cooper Jennifer,Villadolid Desireé,Zervos Emmanuel,Rosemurgy Alexander

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s11605-008-0696-3.pdf

Reference15 articles.

1. Bloomston M, Bekaii-Saab TS, Kosuri K et al. Preoperative carbohydrate antigen 19-9 is most predictive of malignancy in older jaundiced patients undergoing pancreatic resection. Pancreas 2006;33:246–249. doi: 10.1097/01.mpa.0000236726.34296.df .

2. Wray CJ, Ahmad SA, Matthews JB, Lowy AM. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology 2005;6:1626–1641. doi: 10.1053/j.gastro.2005.03.035 .

3. Picozzi VJ, Kozarek RA, Traverso LW et al. Interferon-based adjuvant chemoradiation after pancreaticodudenectomy for pancreatic cancer. Am J Surg 2003;185:476–80. doi: 10.1016/S0002-9610(03)00051-5 .

4. Locker GY, Hamilton S, Harris J et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;33:5313–5327. doi: 10.1200/JCO.2006.08.2644 .

5. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet 1979;5:957–971. doi: 10.1007/BF01542654 .

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gaining a new angle on pancreas cancer: A pre-operative thrombelastographic parameter predicts recurrence and survival among patients with resected periampullary and pancreatic adenocarcinoma;The American Journal of Surgery;2024-12

2. Tumor Size Reduction and Serum Carbohydrate Antigen 19-9 Kinetics After Neoadjuvant FOLFIRINOX in Patients With Pancreatic Ductal Adenocarcinoma;Surgery;2024-02

3. Surveillance With Serial Imaging and CA 19-9 Tumor Marker Testing After Resection of Pancreatic Cancer;American Journal of Clinical Oncology;2023-10-09

4. Letter to the Editor Re: Yamamoto R, Sugiura T, Ashida R, Ohgi K, Yamada M, Otsuka S, and Uesaka K. Prognostic value of carbohydrate antigen 19‐9 and the surgical margin in extrahepatic cholangiocarcinoma. Ann Gastroenterol Surg. 2022; 6:307–315;Annals of Gastroenterological Surgery;2023-01-12

5. Comment on “Usefulness of artificial intelligence for predicting recurrence following surgery for pancreatic cancer: Retrospective cohort study”;International Journal of Surgery;2021-10